Nianzeng Xing

20PUBLICATIONS
38CO-AUTHORS
Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 14, 2026
A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors.

Xiaotian Zhao, Weiqiang Jing, Ganyu Wang

|Mar 10, 2026
A Redox-Responsive Selenium-Containing Nanomedicine Enables Dual Antioxidant System Inhibition to Overcome Platinum Resistance and Enhance Immunotherapy in Bladder Cancer.

Yunhao Gao, Feiya Yang, Lu Yin

|Feb 23, 2026
Clinical Characteristics and Management of Two Cases of Complete Androgen Insensitivity Syndrome With Germ Cell Tumors.

Fangming Wang, Dong Wang, Jianxing Li

|Aug 11, 2025
Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET-Targeted Prostate Biopsy for Prostate Cancer Diagnosis.

Jianhua Jiao, Shuaijun Ma, Peng Wu

|Apr 21, 2025
PSMA-Targeted Nanoparticles with PI3K/mTOR Dual Inhibitor Downregulate P-Glycoprotein and Inactivate Myeloid-Derived Suppressor Cells for Enhanced Chemotherapy and Immunotherapy in Prostate Cancer.

Lu Yin, Feiya Yang, Wenkuan Wang

|Mar 28, 2025
Spatial relationships and interactions of immune cell niches are linked to the pathologic response of muscle-invasive bladder cancer to neoadjuvant therapy.

Wasilijiang Wahafu, Quan Zhou, Xihua Yang

Pageof 4

Frequent Collaborators

3 joint publications

Fangming Wang

2 joint publications

Haihua Xiao

1 joint publications

Qinxin Zhao

1 joint publications

Dehua Chang